HHS Research Awards: Use of Recovery Act and Patient Protection and Affordable Care Act Funds for Comparative Effectiveness Research
Abstract
Comparative effectiveness research (CER) is research comparing different interventions and strategies to prevent, diagnose, treat, and monitor health conditions. The American Recovery and Reinvestment Act of 2009 (Recovery Act) appropriated $1.1 billion to the Department of Health and Human Services (HHS) specifically for CER, including $400 million to the Secretary of HHS, $300 million to the Agency for Healthcare Research and Quality (AHRQ) ,and $400 million to the National Institutes of Health (NIH). The Recovery Act required that these funds be obligated by September 30, 2010. For grants and cooperative agreements, funds are drawn down by recipients on an as-needed basis in accordance with the objectives of the project. For contracts, as milestones are met, invoices are submitted to HHS for payments for goods and services provided under the contract.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 14, 2011
- Accession Number
- AD1178907
Entities
People
- Andrea E. Richardson
- E. A. Laffoon
- Krister Friday
- Linda T. Kohn
- Lisa Motley
- Mary Griffin
- Rebecca Rust
- Rotimi Adebonojo
- Shaunessye Curry
- Will Simerl
Organizations
- United States Government Accountability Office